Table 1 Baseline characteristics of the patients with and without SAP
Variables | Total (n = 233) | Non-SAP (n = 102) | SAP (n = 131) | P |
|---|---|---|---|---|
Demographics | Â | Â | Â | Â |
 Age (years) | 67.52 ± 12.68 | 66.55 ± 11.80 | 68.27 ± 12.68 | 0.197 |
 Male (%) | 147 (63.09) | 64 (62.75) | 83 (63.36) | 0.923 |
Comorbidities (%) | Â | Â | Â | Â |
 Hypertension | 128 (54.94) | 58 (56.86) | 70 (53.44) | 0.602 |
 Diabetes | 43(18.45) | 23 (22.55) | 20 (15.27) | 0.155 |
 Atrial fbrillation | 66 (28.33) | 25 (24.51) | 41 (31.30) | 0.254 |
Clinical parameters | Â | Â | Â | Â |
 Admission NIHSS score | 12 (8, 16) | 11 (6, 15) | 13 (10, 18) | 0.004 |
 Procedural time (min) | 95 (65, 125) | 80.5 (55, 101.75) | 110 (77.5, 140) | 0.000 |
 Dysphagia (%) | 48 (20.60) | 12 (11.76) | 36 (27.48) | 0.003 |
 Occlusion site (%) |  |  |  | 0.060 |
  Anterior circulation | 204 (87.55) | 94 (92.16) | 110 (83.97) |  |
  Posterior circulation | 29 (12.45) | 8 (7.84) | 21 (16.03) |  |
Laboratory parameters | Â | Â | Â | Â |
 WBC (×109/L) | 9.7 (7.68, 11.36) | 9.06 (7.07, 10.91) | 10.21 (8.08, 11.72) | 0.007 |
 Neutrophils (×109/L) | 7.56 (5.47, 9.44) | 7.07 (5.12, 9.06) | 8.12 (6.06, 9.97) | 0.002 |
 Lymphocyte (×109/L) | 1.24 (0.90, 1.70) | 1.33 (1.02, 1.79) | 1.21 (0.83, 1.61) | 0.036 |
 Eosinophils (×109/L) | 0.05 (0.02, 0.13) | 0.08 (0.02, 0.12) | 0.03 (0.01, 0.10) | 0.007 |
 NLR (%) | 6.23 (3.65, 10.02) | 5.31 (2.86, 7.76) | 6.91 (4.01, 11.25) | 0.011 |
 Fibrinogen (g/L) | 3 (2.63, 3.61) | 3.02 (2.64, 3.61) | 3 (2.62, 3.60) | 0.845 |
 Serum calcium (mmol/L) | 2.26 ± 0.13 | 2.27 ± 0.14 | 2.26 ± 0.13 | 0.420 |